2023-06-01 11346476 2024-05-31 11346476 2023-06-01 2024-05-31 11346476 2023-05-31 11346476 2022-06-01 2023-05-31 11346476 uk-core:WithinOneYear 2023-05-31 11346476 uk-core:WithinOneYear 2024-05-31 11346476 uk-core:AfterOneYear 2023-05-31 11346476 uk-core:AfterOneYear 2024-05-31 11346476 uk-core:ShareCapital 2024-05-31 11346476 uk-core:ShareCapital 2023-05-31 11346476 uk-core:RetainedEarningsAccumulatedLosses 2024-05-31 11346476 uk-core:RetainedEarningsAccumulatedLosses 2023-05-31 11346476 uk-bus:Director1 2023-06-01 2024-05-31 11346476 uk-core:PlantMachinery 2023-06-01 2024-05-31 11346476 uk-core:WithinOneYear uk-core:Secured 2024-05-31 11346476 uk-core:WithinOneYear uk-core:Secured 2023-05-31 iso4217:GBP xbrli:pure 11346476 uk-bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 11346476 uk-bus:FRS102 2023-06-01 2024-05-31 11346476 uk-bus:FilletedAccounts 2023-06-01 2024-05-31 11346476 uk-bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31
Skin Derm Ltd
Registered Number:11346476
For the year ended 31 May 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 31 May 2024
Skin Derm Ltd
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
3
Registered Number :
11346476
As at 31 May 2024
Skin Derm Ltd
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
671
981
2
671
981
Current assets
Inventories
-
1,000
3
Trade and other receivables
5,813
5,812
4
1,340
Cash and cash equivalents
1,044
7,856
7,153
Trade and other payables: amounts falling due within one
year
(31,101)
(42,615)
5
(23,948)
(34,759)
Net current liabilities
Total assets less current liabilities
(34,088)
(22,967)
Trade and other payables: amounts falling due after more
than one year
(10,417)
-
6
(34,088)
Net liabilities
(33,384)
Capital and reserves
Called up share capital
1
1
Retained earnings
(34,089)
(33,385)
(34,088)
(33,384)
Shareholders' funds
For the year ended 31 May 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Miss Michalina Koeller Director
These financial statements were approved and authorised for issue by the Board on 12 February 2025 and were signed by:
1 of 4
4
Registered Number :
11346476
For the year ended 31 May 2024
Skin Derm Ltd
Statement of Financial Position Continued
The notes form part of these financial statements
2 of 4
5
For the year ended 31 May 2024
Skin Derm Ltd
Notes to the Financial Statements
Statutory Information
Skin Derm Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number
11346476.
Registered address:
590 Stoney Stanton Road
Coventry
CV6 5FS
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
Going concern
The Director have confirmed that will continue to ensure that the company has adequate funding to meet its
obligations as they fall due for a period 12 months from the date of approval of these financial statements.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts.
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery
25 % Straight line
2. Property, plant and equipment
Plant and
Machinery
£
Cost or
valuation
At 01 June 2023
1,239
At 31 May 2024
1,239
Provision for depreciation and impairment
At 01 June 2023
258
Charge for year
310
At 31 May 2024
568
At 31 May 2024
Net book value
671
At 31 May 2023
981
3 of 4
6
For the year ended 31 May 2024
Skin Derm Ltd
Notes to the Financial Statements Continued
3. Inventories
2023
2024
£
£
Stocks
1,000
-
4. Trade and other receivables
2023
2024
£
£
Other debtors
5,812
5,813
5. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Bank loans and overdraft (secured)
-
5,000
Trade creditors
490
3,371
Other creditors
42,125
22,730
42,615
31,101
6. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Bank loans and overdraft (secured)
-
10,417
7. Average number of persons employed
During the year the average number of employees was 1 (2023 : 1)
4 of 4